Teknik-Anestesi-Umum.ppt

Embed Size (px)

Citation preview

  • GENERAL ANESTHESIADr. Emilzon Taslim, Sp. An. M.KesMedical Faculty University of AndalasM. Djamil Hospital

  • ANESTHESIAGENERALIntravenousInhalationIntramuscularLOCALTopicalInfiltrationBlock peripheral nerveSpinalEpiduralCaudalIVRACOMBINATIONSpinal + propofol

  • General anesthesiaA reversible state of unconsciousness produced by anesthetic agent, with loss of sensation of pain over the whole body.Reversible irregular CNS depression. General anesthetic drugs are administered by inhalation, intravenously, intramuscularly, orally, rectally.

  • The order of descending depression of the CNSCortical and psychic centersBasal ganglia and cerebellumSpinal cordMedullary centers

  • GENERAL ANESTHESIATRIAS ANESTHESIAHypnoticAnalgesicRelaxationBALANCED ANESTHESIA

  • Balance anesthesia

    Anesthesia componentDrugsHypnoticPentothal, Propofol, Enflurane, Isoflurane, SevofluraneAnalgesicPethidine, Morphine, Fentanyl, Sufentanil, RemifentanilRelaxationSucc choline, Atracurium, Cisatracurium, Pancuronium

  • Anesthetic drugsVolatile anesthetic inhalation : Halogen hydrocarbon (halothane) Halogen ether: enflurane, isoflurane, desflurane, sevofluraneGas anesthetic inhalation : cyclopropane, N2O, ethylene.Intravenous : thiopental, propofol, ketamine, etomidate, diazepam, midazolam

  • Concept balanced anesthesia

    Component anesthesiaVIMATIVAHypnoticSevo, Iso, Enf, Hal, DesfluranPropofol, Pento, Ket, MidAnalgesicFentanyl, alf, suf ,Mo, pethidine, remifentanil Fentanyl, alf, suf ,Mo, pethidine, remifentanilRelaxationDepol & non depolDepol & non depol

  • Indication general anesthesiaInfant and young children.Adult who prefer general anesthesia.Extensive surgical proceduresPatient with mental diseaseProlonged surgeryPatient with a history of toxic or allergic reaction to local anesthetic drugsPatient on anticoagulant treatment

  • General anesthesiaInduction inhalation, maintenance anesthesia with inhalation anesthetic (VIMA)Induction intravenous , maintenance anesthesia with intravenous anesthetic (TIVA)Induction intravenous, maintenance anesthesia with inhalation anesthetic

  • General anesthesia techniqueSpontaneous breathingControlled ventilation

    Face maskIntubationLMA (Laryngeal Mask Airway)COPA (Cuffed Oro Pharyngeal Airway)LSA (Laryngeal Seal Airway)

  • ConcentrationofAnestheticAgent

  • Techniques of general inhalation anesthesiaOpen-drop techniqueInsufflationAyre T-piece systemSystem with non-rebreathing valveSemiclosed Closed

  • Breathing circuit systemOpen systemSemi open systemSemi closed systemClosed system

  • Flow Rate Definition :Metabolic-flow: 250 ml/minuteMinimal-flow : 250 - 500 ml/minuteLow-flow : 500 - 1000 ml/minuteMedium-flow : 1-2 liter/minuteHigh-flow: 2-4 liter/minute

  • Advantageous Low-flow anesthesiaLess of anesthesia gas consumptionLess of pollutionHeat loss decreaseCost effective

  • THE EQUIPMENT

  • Component anesthesia machineGas sources : Oxygen, N2OReducing valve or pressure regulatorFlow meter Vaporizer for halothane, enflurane, isoflurane, desflurane or sevoflurane.CO2 absorption system (soda lime or bara lime)

  • SEE THE MOVIE

  • L.Heart

    R.Heart

    FA

    Circulation

    V.R.G.BrainHeartSplancKidney

    M.G.

    V.P.G.

    % %

    20 55

    75

    7

    5

    38

    Pa

  • Uptake and distributionRespiration factorCirculation factorAnesthetic gas factorTissue factor

  • Respiration factorInspiration concentrationVentilation effect

  • Circulation FactorSolubility (partition coefficient)Cardiac outputThe difference of gas partial pressure alveoli and vein

  • Partition coefficient of anesthetic

    AnestheticBlood/gasBrain/bloodTissue/bloodEtherHalothaneEnfluraneIsofluraneN2O12.12.31.81.40.471.12.62.63.71.10.92.51.74.01.2

  • Anesthetic gas factorMAC (Minimal Alveolar concentration)MAC 50, MAC 95MAC Ei 50, MAC Ei 95MAC BAR 50, MAC BAR 95

  • MAC inhalation anestheticMAC =minimal alveolar concentration, in 1 atmosphere, 50% patient without movement in noxious stimuli MAC Ei = concentration of volatile agent permitting laryngoscopy and intubation without untoward movement.MAC BAR = concentration of volatile agent required to block adrenergic response to skin incision

  • MAC inhalation anesthetic, 40 years old.

    Volatile anestheticMACHalothaneEnfluraneIsofluraneDesfluraneSevofluraneN2O0,721.681.126.02.05105.2

  • Factors influencing or not influencing MAC

    MAC decreasedMAC unchangedMAC increasedIncreasing ageCNS depressant: alcohol, barbiturate, lidocaine, benzodiazepine, narcoticDuration of anesthesiaGenderSpeciesHypertensionHypocarbiaAlcoholism chronicHyperthermia > 42HypercarbiaAnemia

  • Tissue factorTissue rich vessel : brain, heart, endocrine, kidney.Intermediate : muscle, skin. Fat.Tissue poor vessel : ligament, tendon.

  • General anesthesia planningPre operative visitPremedicationAnesthesia technique : General, RegionalIntraoperativePostoperative

  • Anesthesia technique :General anesthesiaAirway controlledInductionMaintenance anesthesiaAnalgesiaMuscle relaxation

  • IntraoperativeMonitoringPatient positionCrystalloid and colloidSpecial technique

  • PostoperativePost operative pain treatmentSend patient to Ward or ICU

  • INTRAVENOUS ANESTHETIC

  • Intravenous anestheticPentothalPropofol EtomidateMidazolamDiazepam

  • Ideal intravenous anestheticWater solubleNon irritationNo anta analgesic effectRapid and smooth InductionCardiovascular stable in clinically dose

  • ThiopentoneBlood pressure decreaseHeart rate increase or decreasePeripheral vasodilatationHeart contraction depressedLarynx spasm, bronchus spasmRespiratory depression until apnoeaDose 4-6 mg/kg BW

  • Relative contraindication thiopentoneAsthma bronchialeSevere liver diseaseSevere kidney diseaseSevere anemiaHypotensionShock

  • KetamineDissociative anestheticDeliriumHallucinationIncrease blood pressure : systolic 23% from base lineIncrease heart rateArrhythmiasHypersecretionDose 1-3 mg/kg I.v or 9-11 mg/kg I.m

  • Indication and Contraindication KetamineIndication : short surgeryContraindication : Hypertension systolic > 160 mmHgArrhythmiasHeart failurePharynx and larynx surgery without intubation.

  • PropofolNew intravenous anestheticFast onset, short duration of actionAccumulation minimalFast recoveryRapid metabolismNo complication at site of injection Dose 2-2.5 mg/kg BW

  • Pharmacology PropofolNo histamine release/reaction anaphylactoid (chremophor El change with soya bean oil).Perivascular injection, tissue necrosis negative. Injection intra artery : tissue necrosis negative.

  • Effect Propofol to CNSHypnotic effect 1,8 time pentothalAirway depression > pentothalAnti emetic effectNo anti convulsant effect

  • Comparative properties of intravenous anesthetics

    ThiopenKetaminPropofDiazepMidazAqueous solutionAvailable in solutionPain on injectionVenous thrombosis+

    -

    -

    -+

    +

    -

    --

    +

    +

    --

    +

    +

    ++

    +

    -

    -

  • Comparative properties of intravenous anesthetics

    ThiopenKetaminPropofDiazepMidazRapidly actingSmooth inductionRespiratory depressionCardiovascular depression+

    ++

    +

    ++-

    +

    -

    -+

    +

    +

    ++-

    +

    -

    +/--

    +

    +/-

    +/-

  • Comparative properties of intravenous anesthetics

    ThiopenKetaminPropofDiazepMidazRapid recoverySmooth recoverySuitable for infusionInteraction with relaxant-

    +

    -

    --

    -

    +/-

    -+

    +

    +/-

    --

    -

    -

    --

    -

    -

    -

  • Resume: Effect anesthetic non volatile to organ system

    DrugHRMAPVent BdilThiopentoneDiazepamMidazolamMeperidineMorphineFentanylKetaminePropofol0/ 0**00**0 0

  • Resume: Effect anesthetic non volatile to CNS

    DrugCBFCMRO2ICPThiopentoneDiazepamMidazolamMeperidineMorphineFentanylKetaminePropofol

  • INHALATION ANESTHETIC

  • Choice of anesthetic inhalationCardio pulmonal effectProduct degradation with soda limeWhat metabolites ?How much metabolism?

  • Ideal anesthetic inhalationPleasant odor and non irritationLow solubilityNo organ toxicSide effect cardiovascular and respiration minimalCNS effect reversible without stimulant activityEffective in high O2 concentration Boiling pressure and boiling point can delivered by vaporizer standard

  • New Trend in General AnesthesiaVIMA Fast-Track AnesthesiaLow-flow AnesthesiaLow-cost AnesthesiaSingle-breath induction (Rapid induction)

  • Physicochemical propertiesHalothaneEnflIsofl Desfl SevoOdor + - - - +Irritating to Resp system - + + + -Solubility2,351,91 1,40,42 0,63MAC0,761,68 19156,0 2,05Metabolism17-20%2,4%
  • Interaction with Sodalime

    Anestheticdegradation Product organ Toxicityclinical RelevancyHalothaneBCDFENephrotoxicNon identified to dataEnfluraneCO--IsofluraneCO--DesfluraneCO--SevofluraneCompound ACompound BNephrotoxicNon identified to date

  • WHY VIMA???intravenous induction, ex: Propofol : rapid and smooth induction, but need vein access first, hypotension, apnoe.Pediatric anesthesia commonly by VIMA.More advantages than intravenous induction, maintenance inhalation.

  • Cardiovascular effect of Volatile inhalational anesthetics

    VariableHalothaneEnfluraneIsofluraneBlood pressureVascular resistanceCardiac outputCardiac contractionCVPHeart rateSensitization of the heart to epinephrine 0 0 0000?0 = No change (

  • Clinical pharmacology of Inhalational anesthetics : Respiratory

    N2OHaloEnflurIsoflu SevofluTidal volumeResp ratePaCO2 resting

  • Clinical pharmacology of Inhalational anesthetics : CNS

    N2OHaloEnflurIsoflu SevofluCBFICPCMRO2Seizure

  • Clinical pharmacology of Inhalational anesthetics

    N2OHaloEnflurIsoflu SevofluHBF Nondep blockadeMetabolism

    0.004

    15-20

    2.5

    0.2

    2-3

  • N2O1.5 time heavier than airMust be give with O2 100%Weak anestheticAnalgesic N2O 20% equal with 15 mg morphineDont use in closed systemAt the end of anesthesia, to prevent diffusion hypoxia O2 100%

  • Advantages N2ORapid induction and recoveryNo sensitized myocardium with catecholamineNo irritation respiratory tractOdor pleasantStrong analgesic

  • Disadvantages N2OWeak anestheticNo muscle relaxation effectNeed high concentration oxygenPossibility aplasia bone marrow

  • HalothaneA clear, colorless, potent volatile liquid.Metabolism 17-20%

  • Advantages HalothaneRapid, smooth induction and recovery.PleasantNon irritating, no secretionBronchodilatorNonemeticNon flammable and non explosive

  • Disadvantages HalothaneMyocardial depressantAn arrhythmia producing drugSensitizes the myocardial conduction system to the action of catecholaminesA potent uterine relaxantPossible toxic to the liverShivering during recovery period.

  • EnfluraneA clear, colorless, stable volatile liquid with a pleasant ether-like odor.A potent inhalation anesthetic CNS excitationUse of epinephrine : saver than halothane.

  • Advantages EnfluranePleasantRapid induction and recoveryNon-irritating : no secretionBronchodilatorGood muscle relaxationNonemeticNon flammable and non explosiveCompatible with epinephrine

  • Disadvantages EnfluraneMyocardial depressantShivering on emergenceCSF production increaseCNS excitation, in high dose and hypocarbia.

  • IsofluraneA stabe, volatile liquidA isomer enfluraneInhalation anesthetic choice for neurosurgical patient, kidney, liver.

  • Advantages IsofluraneRapid induction of anesthesia and swift recoveryNonirritating : no secretionBlood pressure remain stableIndicated in poor-risk patient

  • Disadvantages IsofluraneLess than halothane and enflurane

  • SevofluraneInhalation anesthetic with low solubility (0,63), low MAC (2,05), pleasant odor, no airway irritation, rapid uptake and elimination , cardio vascular stable.Rapid induction, with technique single breath induction, induction time 23 seconds.

  • SevofluraneDrugs of choice for Neuro anesthesia : WCA 2000 Montreal, Canada.Drugs of choice for Pediatric Anesthesia : ESA Barcelona, 1998. ASPA, Singapore, 2000., ESA Sweden 2001.In Sectio Caesarea equal with Isoflurane and spinal anesthesiaReduce sphlannic blood flow, hepatic blood flow lesser than other anesthetic inhalation.

  • NARCOTIC ANALGESIC

  • Narcotic analgesic ideal :

    Wide margin of safetyFast onset of actionShort duration of actionEasier analgesia controlledStrong analgesic no histamine releaseNon active metabolite

  • Opiate in Anesthesia

    1. Premedication2. Induction Anesthesia3. Narcotic anesthesia4. A part of balanced anesthesia5. Adjuvant in regional anesthesia6. Neurolept anesthesia7. Post operative pain relief

  • Drugs Protein binding Lipid solubility

    Morphine ++ +Pethidine +++ ++Fentanyl +++ ++++Sufentanil ++++ ++++Alfentanil ++++ +++

    Note : + = very low; ++ = low; +++ = high ++++ = very high

    Morgan GE. Clinical Anesthesiology, 1996.

  • Narcotic effect :

    Bradycardia : central vagotonic effect & SA & AV node depression Respiratory depression : respiratory rate, rhythm, Response CO2, Minute Volume, Tidal VolumeMuscle stiffnessNausea vomiting cause by stimulation CTZ, GIT mobility, decrease gastric mobility, increased gastric volume

  • Clinical Doses of Narcotics

    Drugi.v doseOnset (min)Approximate durationMorphineMeperidineFentanylSufentanilAlfentanil0.05-0.3 mg/kg0.5-1 mg/kg1-5 ug/kg10-40 ug/kg30-80 ug/kg5-105-102

  • MUSCLE RELAXANT

  • Muscle relaxantVery useful in general anesthesia.laryngoscopy and intubation more easier and avoid injuryMuscle relaxation very useful during surgery and controlled ventilation

  • Ideal muscle relaxantNon depolarizationRapid onset, short duration of actionRapid recovery, high potencynon cumulative, metabolite non activeNo cardiovascular effectNo histamine releaseCounteract with anticholinesterase

  • Mechanism neuromuscular blockadeCompetitive block : non-depol, avoid AcCh access to receptor.Depolarization block : depol, depolarization as AcCh but permanentDeficiency block: influence syntesis and release AcCh: Procaine, toxin botulinus, Ca decrease, Mg increase. Morgan GE, Mikhail MS. Clinical Anesth, 1996

  • Terminology in muscle relaxantED 50 : dose what can paralyzed 50% muscle strengthED 90 : dose what can paralyzed 90% muscle strength.Onset : interval between start of injection until maximal effect

  • Table 9 - 1. Depolarizing and nondepolarizing muscle relaxants.

    Depolarizing

    Nondepolarizing

    Short-acting

    Succinylcholine

    Decamethonium

    Long-acting

    Tubocurarine

    Metocurine

    Doxacurium

    Pancuronium

    Pipecuronium

    Gallamine

    Intermediate-acting

    Atracurium

    Vecuronium

    Rocuronium

    Short-acting

    Mivacurium

  • Nondepolarizing drugDo not produce muscular fasciculationEffect are decreased by anticholinesterase agent, depolarizing agent, lowered body temperature, epinephrine, acetylcholineEffect are increased by non-depolarizing drugs, volatile anesthetic .

  • Depolarizing drugsProduce muscular fasciculation .Effect are increased by anticholinesterase agent, Acetylcholine, hypothermiaEffect decrease with non-depolarizing relaxant drugs, anesthetic inhalationDose Succ choline : 1 mg/kg BW

  • Burn injuryMassive traumaSevere intra-abdominal infectionSpinal cord injuryEncephalitisStrokeGuillain-Barre syndromeSevere Parkinsons diseaseTetanusProlonged total body immobilizationRuptured cerebral aneurysmPolyneuropathyClosed head injuryNear drowningHemorrhagic shock with metabolic acidosisMyopathies ( eg, Duchenness dystrophy )Table 9 - 5. Conditions causing susceptibility to succiniylcholine-induced hyperkalemia.

  • Table 9 - 6. A summary of the pharmacology of nondepolarizing muscle relaxant

    Sheet1

    RelaxantMetabolismPrimaryOnsetDurationHistamineVagalRelativeRelative

    ExcretionReleaseBlockadePotency1Cost2

    TubocurarineInsignificantRenal++++++++01Low

    MetocurineInsignificantRenal+++++++02Moderate

    Atracurium+++Insignificant+++++01High

    Mivacurium+++Insignificant++++02.5Moderate

    DoxacuriumInsignificantRenal++++0012High

    Pancuronium+Renal+++++0++5Low

    Pipecuronium+Renal+++++006High

    Vecuronium+Biliary++++005High

    RocuroniumInsignificantBiliary+++++0+1High

    1For example, pancuronium and vecuronium are five times more potent than tubocurarine or atracurium

    2Based on average wholesale price per 10 mL; does not necessarily reflect duration and potency

    Onset : + = slow; ++ = moderately rapid; +++ = rapid

    Duration : + = short; ++ = intermediate; +++ = long

    Histamine release : 0 = no effect; + = slight effect; ++ = moderate effect; +++ marked effect

    Vagal blockade : 0 = no effect; + = slight effect; ++ = moderate effect

    Sheet2

    Sheet3

  • Relaxation

    DrugED95 (mg/kg)Recommended intubating dose (mg/kg)Infusion rate for steady state blockade (mg/kg/h)AtracuriumPancuroniumVecuronium0.210.0670.0430.3-0.60.005-0.0080.08-0.10.250.0320.078

  • INDUCTION AND MAINTENANCE OF ANESTHESIA

  • Choice of anesthesia technique depend on:Patient conditionSkill anesthetistSkill surgeonHospital socioeconomi

  • Problem during induction of anesthesiaMain problem : airwaySign of partial obstruction : snoring, crowing, gargling, wheezing, chest retraction, cyanosisSign of total obstruction : air flow from nose/mouth negative, supraclavicular retraction, intercostal retraction, cyanosis

  • Other problem during inductionRespiratory depressionCoughLarynx spasmMucus and salivavomiting

  • Airway controlledWithout equipment : Triple mannuver SafarWith equipment: OPA (Oro Pharyngeal Airway) NPA (Naso Pharyngeal Airway) LMA ( Laryngeal Mask Airway) ETT (Endo Tracheal Tube)

  • Indication IntubationHead and neck surgeryDifficult airwayThoracotomyLaparotomyLateral positionProne positionControlled ventilation

  • Technique laryngoscopy Head positionInsertion laryngoscope bladeVisualization epiglottisLift epiglottisView larynx and surrounding structure

  • Advantages Endotracheal intubationEnsures a patent airwayNormal anatomic dead space (75 ml) is decreased to 25 ml.Ventilation can be assisted or controlledPossibility of aspiration diminished drasticallySuctioning of the lung is facilitated

  • Disadvantages endotracheal intubationIncreases resistance to respirationTrauma to the lips, teeth, nose, throat, larynx.

  • Complication IntubationTeeth ruptureMouth bleedingEndobronchial intubationOesophageal intubationSore throatHypertensionArrhythmias

  • Induction techniqueMask induction / inhalationIntravenousIntra muscularPer rectal

  • Mask Induction with SevofluraneGradual InductionSingle Breath InductionTriple Breath Induction (Multiple Breath Induction)

    Fast technique with Single Breath Induction, without cough, breath holding, spasm larynx.

  • Gradual InductionClassic method for Mask Induction.To decrease respiratory tract irritation and non pungent odor no need for Sevoflurane.Combined with N2O or Oxygen 100%.Concentration Sevo increase 0.5-1,5 vol% every 2-3 breath until anesthesia adequate.Commonly reach in 60-90 seconds with Sevo 7%.

  • Single-Breath InductionPriming circuit with N2O 60% + Sevo 8% 30 seconds.Ask patient for maximal expiration (until residual volume) face mask .Ask patient inspiration maximal (vital capacity), keep 20 seconds, then normal breathing.After eyelash reflex negative, Sevo turn to 2%.

  • Triple Breath InductionA variation from Single Breath InductionAsk patient 3 times deep breath.Difference with Single Breath, no breath holding.Commonly patient sleep, in 2-3 breathing.

  • How to maintain anesthesia ?Maintenance anesthesia depend on deep of anesthesia to reach adequate anesthesia.Commonly with SEVO 1-1,5 vol% depend on type of surgery, spontaneous breathing or controlled.To reduce vol% (MAC) : add N2O or Fentanyl.

  • Sign of deep anesthesiaPRST Score (balanced anesthesia)Guedel sign (ether anesthesia)PRST Score (score 2-4: adequate anesthesia) P = Systolic arterial pressure (mmHg) R = rate (heart rate) S = sweat/ lacrimation T = tear

  • PRST Scoring indexes for Balanced anesthesia

    IndexConditionScoreSystolic arterial pressure (mmHg)

    Heart rate (beats/min)

    Sweat

    Tears or LacrimationLess than control + 15Less than control + 30More than control +30Less than control + 15Less than control + 30More than control +30NilSkin moist to touchVisible beads of sweatNo excess tears when eyelids openExcess teas visible when eyelids openTears overflow from closed eyelid012012012012

  • ExtubationAfter adequate ventilationIn deep anesthesia or after patient awakeClear airwayOxygen 100% after and before extubation

  • Factor which influence total anesthetic inhalation :

    1. Constanta2. Fresh gas flow3. Volume % (MAC)4. Length of surgeryTotal anesthetic inhalation = constanta x fresh gas flow (ml) x vol % x time (minute)

  • If length of surgery 2 h, total Sevoflurane : Inductionfirst 30 secondFresh gas x 1/183x Vol % x timeflow (ml) (minute) 6000 x 1/183 x 8% x 0,5 = 1,33 minute for intubation : 6000x 1/183 x 2% x 3 = 1,93 minute start for low-flow : 3000x 1/183 x 3%x 3 = 1,4second 3 minute: 1000x 1/183 x 1%x 3 = 0,5Operation 2 hours : 1000x 1/183x 1% x 120 = 6,5Total Sevoflurane 11,6 ml

  • TIVA CONTINU

    Propofol 6-10 mg/kg/h + Vecuronium 0.1 mg/kg/h + Fentanyl 2 ug/kgPentotal 1-3 mg/kg/h + Vecuronium 0.1 mg/kg/h + Fentanyl 2 ug/kgKetamine 2 mg/kg/h + Vecuronium 0.1 mg/kg/h + Diazepame 0.25 mg/kgMidazolam 50 ug/kg/h + Ketamine 2 mg/kg/h + Atracurium 0,25 mg/kg/h

  • POSTOPERATIVESee: Lecture of RR and ICU

  • Thank you for your kind attentionTatang BisriBandung, 2001

    *h